Last reviewed · How we verify
NCT04279496: CONFIRM2
Coronary CT Angiography Evaluation for Clinical Outcomes: An International Multicenter Registry
trial in Coronary Artery Disease in 35,000 participants. Enrolling by invitation.
1 June 2027
Quick facts
| Lead sponsor | Cleerly, Inc. |
|---|---|
| Status | ENROLLING BY INVITATION |
| Study type | OBSERVATIONAL |
| Enrollment | 35,000 |
| Start date | 1 June 2020 |
| Primary completion | 1 June 2027 |
| Estimated completion | 1 June 2027 |
| Sites | 1 location across United States |
Conditions studied
- Coronary Artery Disease — all drugs for Coronary Artery Disease →
Sponsor
Cleerly, Inc. — full company profile →
Who can join
18 and older, any sex, with Coronary Artery Disease. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The overall objective of CONFIRM2 is to perform the largest cardiovascular phenotype outcomes study ever.
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
Relationship of age, atherosclerosis and angiographic stenosis using artificial intelligence.
Jonas R, Earls J, Marques H, Chang HJ, et al · · 2021 · cited 15× · PMID 34785589 · DOI 10.1136/openhrt-2021-001832 -
AI-Quantitative CT Coronary Plaque Features Associate With a Higher Relative Risk in Women: CONFIRM2 Registry.
Feuchtner GM, Lacaita PG, Bax JJ, Rodriguez F, et al · · 2025 · cited 14× · PMID 40162910 · DOI 10.1161/circimaging.125.018235
Verify or expand the search:
- PubMed search for NCT04279496
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Coronary Artery Disease
Currently open trials in the same condition.
- NCT07399002 — LONG NAGOMI™ PMCF STUDY · recruiting
- NCT07420582 — Antegrade Autologous Blood Reinfusion After CPB · recruiting
- NCT07493603 — A Study on Yiyang Huoluo Decoction in the Treatment of Coronary Heart Disease · Phase 1, PHASE2 · recruiting
- NCT06535568 — Single vs. Dual Antiplatelet Therapy in Elderly or HBR Patients Undergoing Percutaneous Intervention With DCB (PICCOLETO · NA · recruiting
- NCT07286578 — A Prospective, Multicenter, Randomized Controlled Trial to Investigate the Value of Coronary CT Angiography in the Under · NA · recruiting
Other Cleerly, Inc. trials
Trials by the same sponsor.
- NCT06112418 — A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events · NA · recruiting
- NCT04066062 — Multicentre Registry of CCTA, IVUS and OCT · active not recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04279496 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Cleerly, Inc.
- Last refreshed: 26 November 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04279496.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing